$LIFE - Is it time for Life ? MOEX:LIFE - Is it time for Life ?
Analyst Ratings are so good .... Momentum can keep up ?
Will see... Good Luck ....
−0.95USD
−50.39 MUSD
353.00 KUSD
65.67 M
About aTyr Pharma, Inc.
Sector
CEO
Sanjay S. Shukla
Headquarters
San Diego
Website
Employees (FY)
59
Founded
2005
ISIN
US0021202025
FIGI
BBG001J2P692
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
$LIFE completed cup & handle pattern this week on the 4HPhase 3 trial completion coming up in August but it appears momentum is pulling this up well ahead of it.
$LIFE A New FrontierAhealthy immune system is like Goldilocks’s pudding where if it is too active, then the immune system attacks healthy tissue causing an autoimmune disease, while if it is not that active, then a simple cold could be fatal. The immune system has to be just right to combat diseases without harming hea
aTyr Pharma Announces FDA Orphan Drug DesignationLIFE: aTyr Pharma, Inc.
2022-04-13 08:00:00
aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis
Life rounding bottom with retest of support Round bottom with a breakout then retests of that support. I Will wait for a confirmation candle to see it holds the support
LIFE: Bullish Pennant (89%)Bullish Pennant, not confirmed yet.
If confirmed, could see a PT = 18.40$
Stay humble, have fun, make money!
Nice trades on LIFEscanner showed me LIFE with a high pre-market % value
my entry is a breakout of the 5 min bar.
long or short but onlyf if there is no resistance
tuesdays short had the target prior day high.
for long trade i trail the stop on a 2-3 bar trailing stop
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical TrLIFE: aTyr Pharma, Inc.
2021-09-13 07:30:00
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis
LIFE / aTyr Pharma*investment opportunity - risky ~$40m market capital*
Happy with the risk?
Shown on the above 10-day chart price action has dropped 99% since May 2015 with a 1:14 reverse split in July 2019, price action is severely depressed.
A ‘incredible buy’ opportunity was illuminated in early 2018, however
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of LIFE is 1.62 USD — it has increased by 1.89% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange aTyr Pharma, Inc. stocks are traded under the ticker LIFE.
aTyr Pharma, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
LIFE stock is 3.80% volatile and has beta coefficient of 1.15. Check out the list of the most volatile stocks — is aTyr Pharma, Inc. there?
One year price forecast for aTyr Pharma, Inc. has a max estimate of 35.00 USD and a min estimate of 16.00 USD.
LIFE earnings for the last quarter are −0.20 USD whereas the estimation was −0.23 USD which accounts for 11.50% surprise. Estimated earnings for the next quarter are −0.24 USD. See more details about aTyr Pharma, Inc. earnings.
aTyr Pharma, Inc. revenue for the last quarter amounts to 353.00 K USD despite the estimated figure of 1.50 M USD. In the next quarter revenue is expected to reach 3.42 M USD.
Yes, you can track aTyr Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
LIFE stock has fallen by 8.47% compared to the previous week, the month change is a 19.40% fall, over the last year aTyr Pharma, Inc. has showed a 15.62% decrease.
LIFE net income for the last quarter is −14.76 M USD, while the quarter before that showed −11.34 M USD of net income which accounts for −30.16% change. Track more aTyr Pharma, Inc. financial stats to get the full picture.
Today aTyr Pharma, Inc. has the market capitalization of 109.76 M, it has decreased by 0.54% over the last week.
No, LIFE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LIFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade aTyr Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 59.00 employees. See our rating of the largest employees — is aTyr Pharma, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So aTyr Pharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating aTyr Pharma, Inc. stock shows the strong sell signal. See more of aTyr Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on aTyr Pharma, Inc. future price: according to them, LIFE price has a max estimate of 35.00 USD and a min estimate of 16.00 USD. Read a more detailed aTyr Pharma, Inc. forecast: see what analysts think of aTyr Pharma, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. aTyr Pharma, Inc. EBITDA is −52.18 M USD, and current EBITDA margin is −14.78 K%. See more stats in aTyr Pharma, Inc. financial statements.